Experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we look at how pharmacy compliance intersects with drug diversion. Hear expert insights, real-world examples, and practical strategies to protect your practice and your patients. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Lucas Schulz speaks with Todd Lemke, recipient of the Section of Inpatient Care Practitioners Distinguished Service Award, about the value of ASHP and Section membership and how it has shaped his journey as a pharmacy practice leader.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Interested in advocacy but don’t know where to start? Heard of advocacy as a professional obligation but not sure how to advocate? Join us for a discussion on how you can get involved with advocacy and overcome perceived barriers to participate regardless of your role in the pharmacy workforce! Advocacy is vital across the spectrum of pharmacy practice. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.

Pharmacists are well positioned to help address the ongoing risks and disease burden associated with COVID-19 by recognizing patients at elevated risk who may benefit from treatment, assessing emerging clinical data that support antiviral use, and facilitating access to these therapies. This activity will provide an overview of the current status of COVID-19 across the United States and assess the role of antiviral treatments in improving patient outcomes.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special series featuring speakers and thought leaders from Pharmacy Futures, where we explore the ideas shaping the future of pharmacy practice. In this episode, we sit down with Michael Wolcott to discuss how today’s pharmacy teams are navigating disruptions to resilience, from burnout and compassion fatigue to less visible challenges like “quiet cracking.” This episode explores how these dynamics show up across individuals, teams, and organizations offering a preview of the insights and strategies attendees can expect to learn in this session.

Listen in for a glimpse of what’s ahead, then register to join us at Pharmacy Futures and be part of the full experience.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

What exactly goes into a Pharmacy Administration and Leadership (PAL) residency, and how do you use those skills once the certificate is on the wall? Join an experienced, PAL-trained leader to explore how residency training shapes a career long after graduation through real-world examples of applying leadership, operational, and strategic skills in evolving roles. Whether you are a student considering this path or a new practitioner looking to sharpen your edge, this episode offers a blueprint for building a more intentional professional toolkit and influencing change in any practice setting. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Foundation Literature Awardee for Sustained Contributions Thomas Lodise discusses pharmacy research, collaboration, and advice for new researchers with Kevin Garey.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) remain underrecognized in ambulatory care despite their rising prevalence. In this podcast we will describe disease characteristics of MASLD/MASH and current approved therapies for MASH.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode features Section of Pharmacy Practice Leaders Immediate Past Chair Kat Miller and 2025 Distinguished Service Awardee Rick Couldry discussing what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.